Latest filing published 05 Jun 2026 for LENSAR, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Nicholas T. Curtis is a declared insider at 2 companies (chief executive); the most frequent names are Staar Surgical Co and LENSAR, Inc. We count 27 filings; the first trade dates from 4 April 2006 and the latest from 3 June 2026.
In open-market terms, that means 1 purchase worth €9,336 on one side and 14 sales worth €180k on the other. Netting one side against the other leaves €171k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants and 3 option exercises.
The record was last updated on 5 June 2026 with a share grant in LENSAR, Inc. The latest purchase dates back some time: it was published 6,735 days ago, on 16 May 2008. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations